Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Tumoral Vitamin D Synthesis by CYP27B1 1-α-Hydroxylase Delays Mammary Tumor Progression in the PyMT-MMTV Mouse Model and Its Action Involves NF-κB Modulation.

Endocrinology | 2016

Biologically active vitamin D (1,25-dihydroxycholecalciferol or 1,25(OH)2D) is synthetized from inactive prohormone 25-hydroxycholecalciferol (25(OH)D) by the enzyme CYP27B1 1-α-hydroxylase in kidney and several extrarenal tissues including breast. Although the development of breast cancer has been linked to inadequate vitamin D status, the importance of bioactive vitamin D production within tumors themselves is not fully understood. To investigate the role of tumoral vitamin D production in mammary epithelial cell progression to breast cancer, we conducted a Cre-loxP-mediated Cyp27b1 gene ablation in the mammary epithelium of the polyoma middle T antigen-mouse mammary tumor virus (PyMT-MMTV) mouse breast cancer model. Targeted ablation of Cyp27b1 was accompanied by significant acceleration in initiation of spontaneous mammary tumorigenesis. In vivo, cell proliferation, angiogenesis, cell cycle progression, and survival markers were up-regulated in tumors by Cyp27b1 ablation, and apoptosis was decreased. AK thymoma (AKT) phosphorylation and expression of several components of nuclear factor κB (NF-κB), integrin, and signal transducer and activator of transcription 3 (STAT3) signaling pathways were increased in Cyp27b1-ablated tumors compared with nonablated controls. In vitro, 1,25(OH)2D treatment induced a strong antiproliferative action on tumor cells from both ablated and nonablated mice, accompanied by rapid disappearance of NF-κB p65 from the nucleus and segregation in the cytoplasm. In contrast, treatment with the metabolic precursor 25(OH)D was only effective against cells from nonablated mice. 25(OH)D did not inhibit growth of Cyp27b1-ablated cells, and their nuclear NF-κB p65 remained abundant. Our findings demonstrate that in-tumor CYP27B1 1-α-hydroxylase activity plays a crucial role in controlling early oncogene-mediated mammary carcinogenesis events, at least in part by modulating tumoral cell NF-κB p65 nuclear translocation.

Pubmed ID: 27119753 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


CYP24A1 Antibody (antibody)

RRID:AB_11004684

This unknown targets CYP24A1

View all literature mentions

NFkB p105/p50 Antibody (antibody)

RRID:AB_11031399

This unknown targets NFkB p105/p50

View all literature mentions

Bcl-2 (D17C4) Rabbit mAb (Mouse Preferred) (antibody)

RRID:AB_1903907

This monoclonal targets Bcl-2 (D17C4) Rabbit mAb (Mouse Preferred)

View all literature mentions

CYP27B1 (G-20) (antibody)

RRID:AB_2089401

This polyclonal targets CYP27B1

View all literature mentions

Ki-67 (M-19) (antibody)

RRID:AB_2142374

This polyclonal targets Ki-67

View all literature mentions

Anti-PCNA antibody [PC10] (antibody)

RRID:AB_303394

This monoclonal targets PCNA

View all literature mentions

cyclin D1 (C-20) (antibody)

RRID:AB_631336

This unknown targets Raised against peptide mapping to the C-terminus of Cyclin D1 of mouse origin

View all literature mentions

VDR (C-20) (antibody)

RRID:AB_632070

This polyclonal targets VDR (C-20)

View all literature mentions

STAT3-human (antibody)

RRID:AB_632440

This polyclonal targets STAT3

View all literature mentions

Akt1 (D-17) (antibody)

RRID:AB_633762

This polyclonal targets AKT1

View all literature mentions